IL79696A - Drug particles having constant sustained release - Google Patents

Drug particles having constant sustained release

Info

Publication number
IL79696A
IL79696A IL79696A IL7969686A IL79696A IL 79696 A IL79696 A IL 79696A IL 79696 A IL79696 A IL 79696A IL 7969686 A IL7969686 A IL 7969686A IL 79696 A IL79696 A IL 79696A
Authority
IL
Israel
Prior art keywords
sustained release
drug particles
constant sustained
constant
drug
Prior art date
Application number
IL79696A
Other languages
English (en)
Other versions
IL79696A0 (en
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL79696A0 publication Critical patent/IL79696A0/xx
Publication of IL79696A publication Critical patent/IL79696A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL79696A 1985-08-16 1986-08-12 Drug particles having constant sustained release IL79696A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76674485A 1985-08-16 1985-08-16

Publications (2)

Publication Number Publication Date
IL79696A0 IL79696A0 (en) 1986-11-30
IL79696A true IL79696A (en) 1990-07-26

Family

ID=25077393

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79696A IL79696A (en) 1985-08-16 1986-08-12 Drug particles having constant sustained release

Country Status (14)

Country Link
EP (1) EP0212746B1 (fr)
JP (1) JPS62111916A (fr)
AU (1) AU601694B2 (fr)
CA (1) CA1275049A (fr)
DE (1) DE3678643D1 (fr)
DK (1) DK390486A (fr)
GB (1) GB2179253B (fr)
HK (1) HK60192A (fr)
IE (1) IE59409B1 (fr)
IL (1) IL79696A (fr)
NZ (1) NZ217230A (fr)
PH (1) PH24767A (fr)
SG (1) SG59492G (fr)
ZA (1) ZA866156B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0212745B1 (fr) * 1985-08-16 1991-04-10 The Procter & Gamble Company Particules pour la libération constante de la substance active
EP0212747B1 (fr) * 1985-08-16 1991-04-10 The Procter & Gamble Company Particules d'une substance active à libération constante et immédiate
JP2687448B2 (ja) * 1988-06-22 1997-12-08 大正製薬株式会社 イブプロフェン徐放性製剤
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
EP1064938A1 (fr) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Formes pharmaceutiques à libération contrôlée avec au moins une impulsion temporelle
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
AR052472A1 (es) 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
CA2607949C (fr) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Bifidobacteries de probiotiques felins
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
EP0094123A3 (fr) * 1982-05-06 1984-07-25 THE PROCTER & GAMBLE COMPANY Granulés thérapeutiques
IT1169772B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche per uso orale contenenti sali stabili della s-adenosil-l-metionina
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
EP0212747B1 (fr) * 1985-08-16 1991-04-10 The Procter & Gamble Company Particules d'une substance active à libération constante et immédiate
EP0212745B1 (fr) * 1985-08-16 1991-04-10 The Procter & Gamble Company Particules pour la libération constante de la substance active

Also Published As

Publication number Publication date
DK390486D0 (da) 1986-08-15
IL79696A0 (en) 1986-11-30
GB2179253B (en) 1989-09-20
GB8619565D0 (en) 1986-09-24
NZ217230A (en) 1989-11-28
CA1275049A (fr) 1990-10-09
PH24767A (en) 1990-10-01
GB2179253A (en) 1987-03-04
EP0212746A2 (fr) 1987-03-04
SG59492G (en) 1992-09-04
EP0212746A3 (en) 1987-11-11
IE862200L (en) 1987-02-16
AU601694B2 (en) 1990-09-20
DE3678643D1 (de) 1991-05-16
EP0212746B1 (fr) 1991-04-10
IE59409B1 (en) 1994-02-23
ZA866156B (en) 1988-04-27
DK390486A (da) 1987-02-17
HK60192A (en) 1992-08-21
JPS62111916A (ja) 1987-05-22
AU6119186A (en) 1987-02-19

Similar Documents

Publication Publication Date Title
GB2179254B (en) Drug particles having constant release and immediate release
EP0187703A3 (en) Sustained release preparation
ZA868039B (en) Sustained release tablets
EP0205336A3 (en) Oral sustained release pharmaceutical preparation
IL79696A (en) Drug particles having constant sustained release
EP0195476A3 (en) Therapeutic particles
IL79695A0 (en) Drug particles having constant sustained release
GB8607817D0 (en) Drug preparation
GB2176999B (en) Sustained release medicament
ZA862464B (en) Therapeutic particles
IE850698L (en) Sustained release pharmaceutical capsule
IE851058L (en) Drug release device
PH21756A (en) Drug release device
GB8500394D0 (en) Spherodal particles
GB8500236D0 (en) Projecting particles
IE872675L (en) Sustained release pharmaceutical
GB8529079D0 (en) Pharmaceutical agents
IE850071L (en) Controlled release pharmaceutical formulations
PH23677A (en) Therapeutic particles

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void